Is high-dose rate (HDR) "better than" and low-dose rate (LDR) prostate brachytherapy? A dosimetric study using retrospective data.

被引:0
|
作者
Sankreacha, R [1 ]
Morton, G [1 ]
Al-Hebshi, A [1 ]
机构
[1] Toronto Sunnybrook Reg Canc Ctr, Toronto, ON, Canada
关键词
D O I
10.1118/1.1997706
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To compare high‐dose rate (HDR) and low‐dose rate (LDR permanent seeds) prostate brachytherapy using dosimetric parameters. Method and Materials: From January 2003 to August 2004, 102 HDR prostate implants were planned on the Nucletron PLATO Brachytherapy with subsequent treatment using Nucletron afterloader (I192 stepping source). During this time period, 72 LDR implants were pre‐planned on Varian Variseed Brachytherapy with subsequent treatment using I125 seeds (a combination of loose and stranded seeds). The HDR implants were forward planned using a combination of manual dwell time adjustments and graphical optimization on patient CT images. The LDR implants were pre‐planned based on ultrasound images and post‐implant dosimetry was assessed at one month from CT. For this study, post‐plans were analyzed using Nucletron PLATO Brachytherapy Seeds. Parameters used for comparison included: Conformal index (COIN), Homogeneity Index (HI), Natural Dose Ratio (NDR) as well as volume and dose coverage indices. Maximum dose contribution to critical structures was reported. Results: Our results show the V100 for HDR with a mean of 96.1% is higher than LDR (post‐plan) with a mean of 81.8% (p<0.001). Conformal Index for HDR was 0.701 compared to LDR pre‐plan (COIN=0.627, p<0.001) and post‐plan (0.534, p<0.001). The homogeneity index showed a significant difference between techniques (HDR HI=0.628, LDR pre‐plan HI=0.518, HI post‐plan HI=0.425). The Natural Dose Ratio did not show a large difference (HDR NDR=1.025, LDR pre‐plan NDR=1.041, LDR post‐plan NDR=0.915). Conclusion: It has been shown high‐dose rate brachytherapy for prostate treatment delivers a more conformal and uniform dose throughout the target than low‐dose rate permanent seeds. The dose contribution to the rectum and urethra is much less with high‐dose rate than low‐dose rate. Dose contribution to the target can be tailored using existing optimization routines and newer algorithms for inverse planning that will make the planning procedure simpler. © 2005, American Association of Physicists in Medicine. All rights reserved.
引用
收藏
页码:1957 / 1957
页数:1
相关论文
共 50 条
  • [11] Dosimetric and radiobiological comparison of volumetric modulated arc therapy, high-dose rate brachytherapy, and low-dose rate permanent seeds implant for localized prostate cancer
    Yang, Ruijie
    Zhao, Nan
    Liao, Anyan
    Wang, Hao
    Qu, Ang
    [J]. MEDICAL DOSIMETRY, 2016, 41 (03) : 236 - 241
  • [12] Brachytherapy for Buccal Cancer: From Conventional Low Dose Rate (LDR) or Mold Technique to High Dose Rate Interstitial Brachytherapy (HDR-ISBT)
    Kotsuma, Tadayuki
    Yamazaki, Hideya
    Masui, Koji
    Yoshida, Ken
    Shimizutani, Kimishige
    Akiyama, Hironori
    Murakami, Shumei
    Isohashi, Fumiaki
    Yoshioka, Yasuo
    Ogawa, Kazuhiko
    Tanaka, Eiichi
    [J]. ANTICANCER RESEARCH, 2017, 37 (12) : 6887 - 6892
  • [13] DOSIMETRIC IMPACT OF INTERFRACTION CATHETER MOVEMENT IN HIGH-DOSE RATE PROSTATE BRACHYTHERAPY
    Foster, William
    Cunha, J. Adam M.
    Hsu, I-Chow
    Weinberg, Vivan
    Krishnamurthy, Devan
    Pouliot, Jean
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 80 (01): : 85 - 90
  • [14] Retrospective analysis and comparison of interstitial high dose and low dose rate Brachytherapy (HDR-BT/LDR-BT) of lip tumor
    Friedrich, E. E.
    Behrensmeier, F.
    Isaak, B.
    Kolotas, C.
    Vock, J.
    Curschmann, J.
    Aebersold, D. M.
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2008, 184 : 173 - 173
  • [16] Brachytherapy for cervix cancer: low-dose rate or high-dose rate brachytherapy – a meta-analysis of clinical trials
    Gustavo A Viani
    Gustavo B Manta
    Eduardo J Stefano
    Ligia I de Fendi
    [J]. Journal of Experimental & Clinical Cancer Research, 28
  • [17] Brachytherapy for cervix cancer: low-dose rate or high-dose rate brachytherapy - a meta-analysis of clinical trials
    Viani, Gustavo A.
    Manta, Gustavo B.
    Stefano, Eduardo J.
    de Fendi, Ligia I.
    [J]. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2009, 28
  • [18] An Audit of Toxicity from Low-dose Rate (LDR) Prostate Brachytherapy - Assessment of a New Service
    Mortimer, C.
    Sabharwal, A.
    [J]. CLINICAL ONCOLOGY, 2022, 34 : E4 - E4
  • [19] Dosimetric guidance on using brachytherapy (low-dose-rate or high-dose-rate) to offset a flawed permanent prostate implant
    Zaider, Marco
    [J]. BRACHYTHERAPY, 2009, 8 (01) : 40 - 44
  • [20] High-dose versus low-dose rate brachytherapy in definitive radiotherapy of cervical cancer
    Kucera, H
    Pötter, R
    Knocke, TH
    Baldass, M
    Kucera, E
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2001, 113 (1-2) : 58 - 62